<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825619</article-id>
    <article-id pub-id-type="pmid">36169226</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac828</article-id>
    <article-id pub-id-type="publisher-id">gkac828</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>AlloMAPS 2: allosteric fingerprints of the AlphaFold and Pfam-trRosetta predicted structures for engineering and design</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Tan</surname>
          <given-names>Zhen Wah</given-names>
        </name>
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tee</surname>
          <given-names>Wei-Ven</given-names>
        </name>
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Guarnera</surname>
          <given-names>Enrico</given-names>
        </name>
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3315-8483</contrib-id>
        <name>
          <surname>Berezovsky</surname>
          <given-names>Igor N</given-names>
        </name>
        <!--igorb@bii.a-star.edu.sg-->
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
        <aff><institution>Department of Biological Sciences (DBS), National University of Singapore (NUS)</institution>, 8 Medical Drive, <addr-line>117579</addr-line>, <country country="SG">Singapore</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +65 6478 8269; Fax: +65 6478 9047; Email: <email>igorb@bii.a-star.edu.sg</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-09-28">
      <day>28</day>
      <month>9</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>28</day>
      <month>9</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D345</fpage>
    <lpage>D351</lpage>
    <history>
      <date date-type="accepted">
        <day>15</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>26</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>25</day>
        <month>7</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac828.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>AlloMAPS 2 is an update of the Allosteric Mutation Analysis and Polymorphism of Signalling database, which contains data on allosteric communication obtained for predicted structures in the AlphaFold database (AFDB) and trRosetta-predicted Pfam domains. The data update contains Allosteric Signalling Maps (ASMs) and Allosteric Probing Maps (APMs) quantifying allosteric effects of mutations and of small probe binding, respectively. To ensure quality of the ASMs and APMs, we performed careful and accurate selection of protein sets containing high-quality predicted structures in both databases for each organism/structure, and the data is available for browsing and download. The data for remaining structures are available for download and should be used at user's discretion and responsibility. We believe these massive data can facilitate both diagnostics and drug design within the precision medicine paradigm. Specifically, it can be instrumental in the analysis of allosteric effects of pathological and rescue mutations, providing starting points for fragment-based design of allosteric effectors. The exhaustive character of allosteric signalling and probing fingerprints will be also useful in future developments of corresponding machine learning applications. The database is freely available at: <ext-link xlink:href="http://allomaps.bii.a-star.edu.sg" ext-link-type="uri">http://allomaps.bii.a-star.edu.sg</ext-link>.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>AlloMAPS update: allosteric fingerprints of proteins in AlphaFold database and trRosetta-predicted Pfam domains.</p>
          </caption>
          <graphic xlink:href="gkac828figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Agency for Science, Technology and Research</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001348</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>C210812031</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC2">
    <title>INTRODUCTION</title>
    <p>Despite constantly growing interest in biomedical implications of allostery in general (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>) and in design of allosteric effectors in particular (<xref rid="B3" ref-type="bibr">3–6</xref>), there is only a handful number of clinically approved allosteric drugs most of which were discovered serendipitously (<xref rid="B4" ref-type="bibr">4</xref>). Moreover, it is increasingly recognized that well-established principles and protocols in the screening of ligand libraries against traditional drug targets and their binding sites are not optimal for the identification and design of allosterically acting medicines (<xref rid="B7" ref-type="bibr">7</xref>). The quest for allosteric drugs should be based, therefore, on completely different principles determined by distinct characteristics of allosteric sites and effectors (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>) and by the structural dynamics-based perturbative nature of allostery (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). Specifically, it was suggested that this procedure should start from the search of latent (<xref rid="B11" ref-type="bibr">11</xref>) or design of new non-natural allosteric sites (<xref rid="B12" ref-type="bibr">12</xref>) followed by mutual design and adjustments of the allosteric ligand-site pair in order to achieve required effects (<xref rid="B7" ref-type="bibr">7</xref>). The proposed framework is based on the Structure-Based Statistical Mechanical Model of Allostery (SBSMMA, (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B13" ref-type="bibr">13</xref>)), which provides quantification of allosteric signalling with per-residue resolution, allowing, thus, to tune ligand-site interactions in order to obtain desired allosteric effects (<xref rid="B14" ref-type="bibr">14</xref>). Acknowledging the omnipresence of allostery (<xref rid="B6" ref-type="bibr">6</xref>) and advantages of prospected allosteric drugs (<xref rid="B4" ref-type="bibr">4–6</xref>), which are supported by recent progress in quantitative description of allostery, one may conclude that practically any disease-causing protein can be considered as a target for allosteric drug development (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B7" ref-type="bibr">7</xref>). Recent progress in AI-based structure predictions (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>) delivered the structures of a large number of potential yet unexplored drug targets with uncharacterized allosteric signalling. The goal of this update is to provide a comprehensive information on allosteric communication in predicted structures from the AlphaFold (<xref rid="B17" ref-type="bibr">17</xref>) and Pfam (<xref rid="B18" ref-type="bibr">18</xref>) databases. In addition to Allosteric Signalling Maps (ASMs), which exhaustively describe the signalling in per-residue approximation and allosteric effects of mutations, we computed the Allosteric Probing Maps (APMs) quantifying the allosteric effects of small probe binding, which can be used in fragment-based design of allosteric effectors (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B19" ref-type="bibr">19</xref>). We provide corresponding information for 12 model organism proteomes and 14 proteomes of various pathogens involved in global health issues presented in AlphaFold protein structure database (<xref rid="B17" ref-type="bibr">17</xref>) and for the set of trRosetta-predicted (<xref rid="B15" ref-type="bibr">15</xref>) Pfam domains (<xref rid="B18" ref-type="bibr">18</xref>).</p>
  </sec>
  <sec sec-type="methods" id="SEC3">
    <title>THEORETICAL BACKGROUND AND COMPUTATIONAL METHODS</title>
    <p>We quantified allosteric communication on the predicted structures using the benchmarked Structure-Based Statistical Mechanical Model of Allostery (SBSMMA, (<xref rid="B9" ref-type="bibr">9</xref>)). The model outputs are presented in form of allosteric signalling/probing maps (ASM/APMs, (<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B19" ref-type="bibr">19</xref>)), which show changes in per-residue free energy in response to signals caused by a perturbation: single-residue mutations or small-probe binding to three-residue segments in case of ASM and APM, respectively. The per-residue free energy difference (kcal/mol) between the native <inline-formula><tex-math id="M0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( 0 )$\end{document}</tex-math></inline-formula> and perturbed <inline-formula><tex-math id="M0001a" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( P )$\end{document}</tex-math></inline-formula> states is estimated for each residue <inline-formula><tex-math id="M0002" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>, <inline-formula><tex-math id="M0003" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta \ g_i^{( P )} = \frac{1}{2}\ {k}_BT\mathop \sum \limits_\mu \ln \frac{{\varepsilon _{\mu ,i}^{( P )}}}{{\varepsilon _{\mu ,i}^{( 0 )}}},$\end{document}</tex-math></inline-formula> which depends exclusively on the parameters <inline-formula><tex-math id="M0004" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\varepsilon _{\mu ,i}$\end{document}</tex-math></inline-formula> that characterize the native <inline-formula><tex-math id="M0005" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( 0 )$\end{document}</tex-math></inline-formula> and perturbed <inline-formula><tex-math id="M0006" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( P )$\end{document}</tex-math></inline-formula> protein conformational ensembles. Briefly, the free energy <inline-formula><tex-math id="M0007" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${g}_i = \ - {k}_BT\ln {z}_i$\end{document}</tex-math></inline-formula> is obtained from the per-residue partition function <inline-formula><tex-math id="M0008" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${z}_i = \mathop \prod \limits_\mu {( {\pi 2{k}_BT/{\varepsilon }_{\mu ,i}} )}^{1/2}$\end{document}</tex-math></inline-formula>, which, in turn, is a result of the integration of the allosteric potential over all possible displacements of neighbors of the residue <inline-formula><tex-math id="M0009" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>. The allosteric potential <inline-formula><tex-math id="M00010" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${U}_i\ ( \sigma ) = \ 1/2\mathop \sum \limits_\mu {\varepsilon }_{\mu ,i}\sigma _\mu ^2$\end{document}</tex-math></inline-formula> evaluates the effect of a perturbation on a residue <italic toggle="yes">i</italic> as the elastic work (the implementation of SBSMMA used here is based on a Cα harmonic model of proteins) exerted on <italic toggle="yes">i</italic> due to changes in the displacements of surrounding residues <italic toggle="yes">j</italic> caused by normal modes <inline-formula><tex-math id="M00011" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${{\boldsymbol{e}}}_\mu$\end{document}</tex-math></inline-formula>, where <inline-formula><tex-math id="M00012" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\varepsilon }_{\mu ,i} = \mathop \sum \limits_j {| {{{\boldsymbol{e}}}_{\mu ,i} - {{\boldsymbol{e}}}_{\mu ,j}} |}^2$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00013" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\sigma \ = ( {{\sigma }_1, \ldots ,\ {\sigma }_\mu ,\ \ldots } )$\end{document}</tex-math></inline-formula> is a set of Gaussian distributed amplitudes with variance 1/<inline-formula><tex-math id="M00014" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\varepsilon }_{\mu ,i}$\end{document}</tex-math></inline-formula> (see for details (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>)). We evaluate the allosteric modulation as a deviation of the obtained free energy difference from its mean value over the protein chain, eliminating thus the background allosteric signalling: <inline-formula><tex-math id="M00015" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( P )} = \ {\rm{\Delta }}g_i^{( P )} - {\langle {\rm{\Delta }}g_i^{( P )}\rangle }_{Chain/Protein}$\end{document}</tex-math></inline-formula>. Allosteric modulation close to zero indicates that signalling to the residue/site of interest is similar to the background effect on the whole chain/protein. In terms of mutations, we modelled the effect of UP (<inline-formula><tex-math id="M00016" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m \uparrow$\end{document}</tex-math></inline-formula>) mutations, which represent a substitution of residue <inline-formula><tex-math id="M00017" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula> to the bulkiest ones (for example Phe or Trp), and the resultant free energy change at responding residue <inline-formula><tex-math id="M00018" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula> is expressed as <inline-formula><tex-math id="M00019" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( {m \uparrow } )}$\end{document}</tex-math></inline-formula>. Similarly, DOWN (<inline-formula><tex-math id="M00020" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m \downarrow$\end{document}</tex-math></inline-formula>) mutations model the opposite conversion of a residue <inline-formula><tex-math id="M00021" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula> to the smallest amino acid (Gly-like), and the effect on residue <inline-formula><tex-math id="M00022" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula> is expressed as <inline-formula><tex-math id="M00023" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( {m \downarrow } )}$\end{document}</tex-math></inline-formula>. The allosteric modulation range (kcal/mol) on responding residue <inline-formula><tex-math id="M00024" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula><inline-formula><tex-math id="M00025" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta \ }}h_i^{( {m \downarrow \uparrow } )} = \ {\rm{\Delta }}h_i^{( {m \uparrow } )} - {\rm{\Delta }}h_i^{( {m \downarrow } )}$\end{document}</tex-math></inline-formula> is a measure of the overall allosteric effect on residue <inline-formula><tex-math id="M00026" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula> upon a substitution of the smallest amino acid by the largest one at residue position <inline-formula><tex-math id="M00027" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula>, providing a generic description of the maximal signalling strength from position <inline-formula><tex-math id="M00028" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula> to <inline-formula><tex-math id="M00029" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>. For amino acid changes in the opposite direction, namely from the largest to the smallest residues, the modulation range is <inline-formula><tex-math id="M00030" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta \ h_i^{( {m \uparrow \downarrow } )} = \ - \Delta h_i^{( {m \downarrow \uparrow } )}$\end{document}</tex-math></inline-formula>. Since the signal obtained upon conversion between the largest and the smallest amino acids is the same in absolute value regardless of the direction of the substitution, it serves as an indicator of the dynamic range of the allosteric signal that can be obtained upon mutations of a considered position in the protein sequence/structure. Exhaustive quantification of signalling for all pairwise residue positions is represented in the ASM matrix plot (Figure <xref rid="F1" ref-type="fig">1</xref>). The ASM reveals distant residues/protein regions that are allosterically connected with strong positive or negative signalling, which might indicate conformational changes or stabilization in the affected residues/regions, respectively. On the other hand, to understand and explore the effect of ligand binding to different parts of a protein chain, we exhaustively simulate the binding of a small probe to every consecutive three-residue segment along a protein chain (see (<xref rid="B14" ref-type="bibr">14</xref>) for technical details). The effect of a probe binding on every residue <inline-formula><tex-math id="M00031" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>, <inline-formula><tex-math id="M00032" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( {Probe} )},$\end{document}</tex-math></inline-formula> is represented in the APM matrix plot (Figure <xref rid="F1" ref-type="fig">1</xref>, for details of APM calculation see (<xref rid="B14" ref-type="bibr">14</xref>)). The ASM/APM matrices are presented here in the form of allosteric fingerprints, in which the signalling between proximal residues (see (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B20" ref-type="bibr">20</xref>) for explanations of proximity according to an operational definition of allosteric distances) and/or those with negligible modulation are color-coded (in blue-green), allowing the user to focus on the relevant and strong allosteric communication.</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Flowchart of the datasets added to the AlloMAPS 2 database and its updated features. First row: selection of the dataset, AlphaFold or Pfam-trRosetta. Second row: selection of the organism (left panel) in AlphaFold dataset and of the protein (in both datasets). Third row: description of the protein (left) and optional selection of parts of ASM/APM in case of large structures with more than 1200 residues. Bottom row: selected part of ASM/APM (left/right) and structure (center) of considered here Splicing factor 3B subunit 3.</p>
      </caption>
      <graphic xlink:href="gkac828fig1" position="float"/>
    </fig>
  </sec>
  <sec id="SEC4">
    <title>DESCRIPTION OF THE DATABASE UPDATE</title>
    <p>The original database (<xref rid="B21" ref-type="bibr">21</xref>) contained data on allosteric signalling in more than 2000 proteins and protein chains grouped in three sets: (i) ‘Allosteric proteins’ with the data on allosteric regulation in 48 proteins documented on the basis of experimental works (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B12" ref-type="bibr">12</xref>) originally published in (<xref rid="B22" ref-type="bibr">22</xref>); (ii) ‘PDBselect chains’ set of 1908 protein chains contains representative structures with low sequence identity (less than 25%) providing a ‘list of representative protein chains with low mutual sequence identity selected from the protein data bank (PDB, (<xref rid="B23" ref-type="bibr">23</xref>)), which enables unbiased statistics’ (<xref rid="B24" ref-type="bibr">24</xref>); (iii) ‘Allosteric polymorphism’ set with 33 proteins (<xref rid="B21" ref-type="bibr">21</xref>) with multiple (more than 50 in each protein) known pathology-related SNPs originally obtained in (<xref rid="B25" ref-type="bibr">25</xref>) based on the UniprotKB/Swiss-Prot (<xref rid="B26" ref-type="bibr">26</xref>) Humsavar database (version 2017_09; current version is available at: <ext-link xlink:href="https://ftp.uniprot.org/pub/databases/uniprot/current_release/knowledgebase/complete/docs/humsavar" ext-link-type="uri">https://ftp.uniprot.org/pub/databases/uniprot/current_release/knowledgebase/complete/docs/humsavar</ext-link>) containing all missense variants annotated in human entries.</p>
    <p>The current update includes high-throughput data on allosteric signalling and effects of probing in the predicted structures from the AlphaFold (<xref rid="B16" ref-type="bibr">16</xref>) protein structure database (<xref rid="B17" ref-type="bibr">17</xref>) and the trRosetta (<xref rid="B15" ref-type="bibr">15</xref>) predicted set of Pfam (<xref rid="B18" ref-type="bibr">18</xref>) domains. The original collections of structures were filtered in order to select only structures with sizes larger than typical size of protein domains/folds (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>) and with sufficient quality of predictions (see Materials and Methods for the description of filtering procedure). Table <xref rid="tbl1" ref-type="table">1</xref> contains a list of organisms presented in the AlphaFold database with the total number of initial protein entries available for download and the number of high-quality structures available for browsing in AlloMAPS 2. Remaining structures not satisfying the filtering criteria are available through the search using their accession code listed in downloadable complete lists of proteomes (see online Tutorial and Materials and Methods for details).</p>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>List of AlphaFold proteomes included in the AlloMAPS 2 database update. Quality filters were applied to the predicted structures, requiring that low-confidence residues (LCRs) constitute only a small fraction of the structure and do not form long consecutive segments. Structures with low-confidence signal peptides were also excluded. The Browse function for the database focuses on reasonably large structures with more than 100 residues, yielding about 50 000 proteins in all proteomes presented in this table</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Organism name</th>
            <th rowspan="1" colspan="1">AlphaFold entries with full structure</th>
            <th rowspan="1" colspan="1">Selected entries for browsing</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Homo sapiens</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">20 296</td>
            <td rowspan="1" colspan="1">4073</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Mus musculus</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">21 615</td>
            <td rowspan="1" colspan="1">4989</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Drosophila melanogaster</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">13 458</td>
            <td rowspan="1" colspan="1">2823</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Danio rerio</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">24 664</td>
            <td rowspan="1" colspan="1">5032</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Candida albicans</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5974</td>
            <td rowspan="1" colspan="1">1598</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Caenorhabditis elegans</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">19 694</td>
            <td rowspan="1" colspan="1">4866</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Arabidopsis thaliana</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">27 434</td>
            <td rowspan="1" colspan="1">5126</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Oryza sativa</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">43 649</td>
            <td rowspan="1" colspan="1">5221</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Escherichia coli</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">4363</td>
            <td rowspan="1" colspan="1">2979</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Saccharomyces cerevisiae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">6040</td>
            <td rowspan="1" colspan="1">1540</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Schizosaccharomyces pombe</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5128</td>
            <td rowspan="1" colspan="1">1515</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Methanococcus jannaschii</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1773</td>
            <td rowspan="1" colspan="1">1305</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Staphylococcus aureus</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2887</td>
            <td rowspan="1" colspan="1">1874</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Plasmodium falciparum</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5187</td>
            <td rowspan="1" colspan="1">683</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Pseudomonas aeruginosa</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5556</td>
            <td rowspan="1" colspan="1">3832</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Helicobacter pylori</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1538</td>
            <td rowspan="1" colspan="1">939</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Mycobacterium tuberculosis</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">3988</td>
            <td rowspan="1" colspan="1">2347</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Shigella dysentriae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">3893</td>
            <td rowspan="1" colspan="1">2469</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Campylobacter jejuni</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1620</td>
            <td rowspan="1" colspan="1">1217</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Enterococcus faecium</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2823</td>
            <td rowspan="1" colspan="1">2504</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Salmonella typhimurium</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">4526</td>
            <td rowspan="1" colspan="1">3101</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Haemophilus pneumoniae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1662</td>
            <td rowspan="1" colspan="1">1180</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Streptococcus pneumoniae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2030</td>
            <td rowspan="1" colspan="1">1177</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Kiebsiella pneumoniae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5727</td>
            <td rowspan="1" colspan="1">3784</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Neisseria gonorrhoeae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2106</td>
            <td rowspan="1" colspan="1">1246</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Mycobacterium leprae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1602</td>
            <td rowspan="1" colspan="1">875</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </sec>
  <sec sec-type="materials|methods" id="SEC5">
    <title>MATERIALS AND METHODS</title>
    <p>The predicted structures of 12 key model organisms and 14 pathogens from the AlphaFold protein structure database (<ext-link xlink:href="https://alphafold.ebi.ac.uk/download" ext-link-type="uri">https://alphafold.ebi.ac.uk/download</ext-link>, (<xref rid="B17" ref-type="bibr">17</xref>)) and of 6370 protein families from the Pfam database (<ext-link xlink:href="http://ftp.ebi.ac.uk/pub/databases/Pfam/releases/Pfam33.1/structure_models/" ext-link-type="uri">http://ftp.ebi.ac.uk/pub/databases/Pfam/releases/Pfam33.1/structure_models/</ext-link>, (<xref rid="B18" ref-type="bibr">18</xref>)) were filtered in order to focus on high-quality structures contained in these large datasets. Confidence of residue-level structures were estimated in AlphaFold (<xref rid="B17" ref-type="bibr">17</xref>) using a measure called pLDDT, which is based on the lDDT (local Distance Difference Test) metric (<xref rid="B29" ref-type="bibr">29</xref>) obtained by comparing pairwise distances of C-alpha atoms between predicted and existing reference structures. First, in both AlphaFold and trRosetta predictions, a residue having pLDDT score lower than 70 (equivalently, lDDT score lower than 0.7) indicates low confidence in the prediction. Hence, a structure prediction of high quality should have few or no low-confidence residues (LCRs), and should not have long continuous stretches of low-confidence residues. In alignment with the original AlphaFold publication (<xref rid="B17" ref-type="bibr">17</xref>), residues with scores pLDDT &lt;70 are considered low-confidence residues (LCRs). To this end, we required that the percentage of LCRs in each structure (listed under the column lcr_perc in the downloadable table of structures) be lower than a given threshold (10% for prokaryotes and 20% for eukaryotes), and that the longest continuous stretch of LCRs (lcr_length) be shorter than a given threshold (15 residues for prokaryotes, 25 for eukaryotes)—we set this limit on the basis of polymer nature of protein backbone determining the size of protein chain returns known as closed loops (<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B31" ref-type="bibr">31</xref>). We adopted looser requirements for eukaryotes due to the presence of relatively larger unstructured or disordered regions in eukaryotic proteins (<xref rid="B27" ref-type="bibr">27</xref>). To exclude structures containing low-confidence signal peptides, we further required that the first 20 residues from the N-terminus are not all LCRs. Finally, we considered only structures that are larger than 50 residues in size, guaranteeing at least the protein fold size for considered structures (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>). Corresponding numbers of proteins remaining after selection according to above criteria are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>. The Browse function shows only structures with &gt;100 residues, yielding more than 50 000 high-quality structures (see Table <xref rid="tbl1" ref-type="table">1</xref>) with sizes exceeding the minimal size of protein domain/fold (<xref rid="B28" ref-type="bibr">28</xref>). Other structures can be accessed through the search function using their accession code listed in the downloadable complete lists of proteomes (see online Tutorial for details).</p>
  </sec>
  <sec id="SEC6">
    <title>ORGANIZATION OF THE NEW DATASETS, THEIR NAVIGATION AND USAGE</title>
    <p>Figure <xref rid="F1" ref-type="fig">1</xref> shows a flowchart navigating through the updated parts of the database, as well as generically implemented new features. To browse AlphaFold structures, users can first select a proteome of interest. Clicking on the AlphaFold panel (shown in Figure <xref rid="F1" ref-type="fig">1</xref> along with the Pfam-trRosetta starting panel) in the AlloMAPS home page brings users to the list of organisms with AlphaFold proteomes available in the database. Selecting an organism of interest (Figure <xref rid="F1" ref-type="fig">1</xref>, second row, left panel) generates a list of predicted structures satisfying our quality control criteria and passing the filtering procedure (see Materials and Methods), which enables the users to identify a structure of interest. The list of proteins (Figure <xref rid="F1" ref-type="fig">1</xref>, second row, right panel) starts from structures with the smallest proportion of low-confidence residues. Examples of top25 entries in each organism are presented in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>. Selecting a given structure brings the user to the interactive data dashboard schematically shown in the third level (left panel), where further information about the protein is provided, with links to relevant external resources (for example, AlphaFold and Uniprot).</p>
    <p>Accessing the structure of interest, the users can study how structural perturbations in different parts of the protein can affect distant regions allosterically. In the original version of AlloMAPS, users were able to study the effect of individual mutations by selecting these residues on the ‘Residues: Binding/Mutation’ panel, and also visualize the allosteric signalling map (ASM) as a matrix plot in the corresponding panel. These features have been retained, and we have also added the pre-computed allosteric probing map (APM) for each structure in this update. Furthermore, we have updated the matrix view of the allosteric signalling/probing maps using allosteric fingerprints, masking the effects due to proximal regions and/or weak signalling. Large structures (above 1200 residues) may be studied by zooming into selected, smaller regions of interest (Figure 1, third row, right panel). In case of using the Pfam-trRosetta dataset, the user starts from the corresponding panel on the AlloMAPS homepage, which will open the page with a list of structures, similar to the one for AlphaFold proteins (second row, right panel). Some tasks may require additional and/or preliminary analysis: as an example, oligomerization will definitely originate additional signalling, which will be taking place between protomers and may affect to some extent the original signalling in individual protomers. Therefore, while signalling in protomers can be obtained from the presented database, in order to analyze a complete picture of allosteric signalling in oligomers, it will be necessary to obtain accurate structures of oligomers as an input for the AlloSigMA server (<xref rid="B19" ref-type="bibr">19</xref>) to compute ASMs/APMs. Noteworthy, some low-quality AlphaFold predictions may require special treatments. For example, in case of multi-chain and/or oligomeric proteins the AlphaFold predictions should be performed first for individual chains/protomers followed by the assembly into the final structure.</p>
    <p>Figure <xref rid="F1" ref-type="fig">1</xref> illustrates the example of splicing factor 3B subunit 3, consisting of 1217 amino acid residues, of which first 800 residues were selected (third row, right panel) for building the ASM and APM fingerprints. We would like to specifically emphasize on the appearance of the APM fingerprint. The APM fingerprint (bottom row, right panel) contains, unlike the corresponding ASM’s fingerprint (bottom row, left panel), more areas featuring negligible signalling strength and at short distances, which are filtered out from the original APM (these areas are blue-green masked in the fingerprint). Nevertheless, it is a meaningful result indicating that only a limited number of places can be targeted in order to obtain a strong allosteric signal originated by the probe binding. Another technical improvement we have implemented in this update is the ability to visualize large structures that were previously inaccessible due to memory constraints: for all structures above 1200 residues in size, an extra panel is included to enable users to zoom in on different, smaller regions to examine signalling data on applied perturbation and responses.</p>
  </sec>
  <sec sec-type="conclusions" id="SEC7">
    <title>CONCLUSIONS</title>
    <p>Constantly improving resolution of experimental techniques, such as X-ray crystallography, NMR, and cryoEM and their transformation into high-throughput approaches have provided wealth of experimental data, on protein structures and sequences, in particular. It has allowed, in turn, to use the power of machine learning for predicting protein structures that are difficult to obtain via experiments (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>). Advantages of allosteric medicines (<xref rid="B4" ref-type="bibr">4–7</xref>) over traditional orthosteric ones call for their development targeting established and new drug targets. At the same time, observations on mutations (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B25" ref-type="bibr">25</xref>) triggering different pathologies via allosteric signalling point to the need of their characterization and consideration in diagnostics (<xref rid="B6" ref-type="bibr">6</xref>). The significantly expanded array of potential drug targets provided by the AI-based predictions of protein structures (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>) is especially important for answering the quests for precision/personalized medicine, motivating us to perform this update of the AlloMAPS database. We provide here about 50 000 fingerprints of Allosteric Signalling and Probing Maps (ASMs/APMs) for newly predicted high-quality structures. This update allows to expand the analysis of allosteric communication from the effects of ligand binding and mutations to engineering and design of allosteric signalling (<xref rid="B20" ref-type="bibr">20</xref>) in newly predicted structures, as well as to target them with newly developed allosteric effectors (<xref rid="B7" ref-type="bibr">7</xref>). Specifically, the ASM fingerprints will facilitate diagnostics of different pathologies, helping to predict allosteric effects of mutations and their combinations, and analyzing their role in expansion of cancer landscapes (<xref rid="B32" ref-type="bibr">32</xref>) and triggering other diseases (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>). One of the recent examples of using ASMs as a diagnostic tool demonstrated successful prediction of distant mutations (many of which are associated with variants of concern including the Omicron variant) that might affect the dynamics of the receptor-binding domain of the SARS-CoV-2 Spike protein (<xref rid="B33" ref-type="bibr">33</xref>). The APM fingerprints will be useful in fragment-based design of allosteric drug candidates. The comprehensive nature of ASM/APM fingerprints available in the AlloMAPS database along with extensivity of free energy accounting for allosteric effects in SBSMMA allows one to use these data as an input for future machine learning approaches (<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B35" ref-type="bibr">35</xref>) on diagnostics and drug design (<xref rid="B36" ref-type="bibr">36</xref>).</p>
    <p>The outlook on future work presents several promising research directions that can be explored with the SBSMMA-based (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B12" ref-type="bibr">12–14</xref>) computational suite comprised of the AlloSigMA (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B37" ref-type="bibr">37</xref>) web-server and the AlloMAPS database, as well as corresponding requirements for their further developments. The high-throughput data presented in this update provides an overall picture of allosteric signalling in predicted structures of proteins important in biomedical and biotechnological applications, which can serve as a starting point in diagnostics and engineering/design efforts involving these proteins. Further steps in these efforts may require more accurate consideration of allosteric effects, which can be achieved within the SBSMMA framework by replacing the input normal modes obtained from a C<sub>α</sub> harmonic model of the protein backbone with the principal components of the covariance matrix obtained in atomistic MD simulations of corresponding structures (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B7" ref-type="bibr">7</xref>). The MD-based approach comes, however, at the expense of increased computing time, making it necessary, for practical purposes, to combine data obtained in atomistic simulations with the massive coarse-grained one presented in AlloMAPS. The high-throughput data would also be instrumental for validation and calibration of computational predictions in conjunction with experimental assays (<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B7" ref-type="bibr">7</xref>), such as deep mutational scanning and fragment-based screening. The capability of artificial intelligence (AI) algorithms (<xref rid="B34" ref-type="bibr">34–36</xref>) in performing feature extraction from low-level data representation with non-obvious hierarchical connectivity and to model complex nonlinear input-output relationships can be utilized on the basis of these data. All the above will provide an opportunity to include allosteric regulation as an integral part of protein design procedures (<xref rid="B38" ref-type="bibr">38–41</xref>) and to improve protocols for design of allosteric drugs (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B7" ref-type="bibr">7</xref>), which, in turn, will allow to tackle challenging tasks of targeting so-called undruggable targets (<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>) and regulating multiscale cellular signalling.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC8">
    <title>DATA AVAILABILITY</title>
    <p>The database is freely available at: <ext-link xlink:href="http://allomaps.bii.a-star.edu.sg" ext-link-type="uri">http://allomaps.bii.a-star.edu.sg</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac828_Supplemental_Files</label>
      <media xlink:href="gkac828_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC9">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac828#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC10">
    <title>FUNDING</title>
    <p>Agency for Science, Technology, and Research (A*STAR) under the Career Development Fund [C210812031 to W.V.T.]. Funding for open access charges: Biomedical Research Council, Agency for Science, Technology, and Research (A*STAR).</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Enrico Guarnera, Global Analytical Pharmaceutical Science and Innovation, Merck KGaA, Via Luigi Einaudi, 11, Guidonia Montecelio, 00012 Rome, Italy.</p>
  </notes>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wodak</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Paci</surname><given-names>E.</given-names></string-name>, <string-name><surname>Dokholyan</surname><given-names>N.V.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Horovitz</surname><given-names>A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hilser</surname><given-names>V.J.</given-names></string-name>, <string-name><surname>Bahar</surname><given-names>I.</given-names></string-name>, <string-name><surname>Karanicolas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Stock</surname><given-names>G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Allostery in its many disguises: from theory to applications</article-title>. <source>Structure</source>. <year>2019</year>; <volume>27</volume>:<fpage>566</fpage>–<lpage>578</lpage>.<pub-id pub-id-type="pmid">30744993</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name></person-group><article-title>Multiscale allostery: basic mechanisms and versatility in diagnostics and drug design</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167751</fpage>.<pub-id pub-id-type="pmid">35863488</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Thermodynamics of allostery paves a way to allosteric drugs</article-title>. <source>Biochim. Biophys. Acta</source>. <year>2013</year>; <volume>1834</volume>:<fpage>830</fpage>–<lpage>835</lpage>.<pub-id pub-id-type="pmid">23376182</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Allosteric drugs and mutations: chances, challenges, and necessity</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2020</year>; <volume>62</volume>:<fpage>149</fpage>–<lpage>157</lpage>.<pub-id pub-id-type="pmid">32062398</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>C.J.</given-names></string-name></person-group><article-title>Allostery in disease and in drug discovery</article-title>. <source>Cell</source>. <year>2013</year>; <volume>153</volume>:<fpage>293</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">23582321</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Maloney</surname><given-names>R.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>H.</given-names></string-name></person-group><article-title>Allostery: allosteric cancer drivers and innovative allosteric drugs</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167569</fpage>.<pub-id pub-id-type="pmid">35378118</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Learning about allosteric drugs and ways to design them</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <fpage>167692</fpage>.<pub-id pub-id-type="pmid">35738428</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Disorder driven allosteric control of protein activity</article-title>. <source>Curr. Res. Struct. Biol.</source><year>2020</year>; <volume>2</volume>:<fpage>191</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="pmid">34235479</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Structure-Based statistical mechanical model accounts for the causality and energetics of allosteric communication</article-title>. <source>PLoS Comput. Biol.</source><year>2016</year>; <volume>12</volume>:<fpage>e1004678</fpage>.<pub-id pub-id-type="pmid">26939022</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>On the perturbation nature of allostery: sites, mutations, and signal modulation</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2019</year>; <volume>56</volume>:<fpage>18</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">30439587</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Allosteric sites: remote control in regulation of protein activity</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2016</year>; <volume>37</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">26562539</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Reversing allosteric communication: from detecting allosteric sites to inducing and tuning targeted allosteric response</article-title>. <source>PLoS Comput. Biol.</source><year>2018</year>; <volume>14</volume>:<fpage>e1006228</fpage>.<pub-id pub-id-type="pmid">29912863</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Toward comprehensive allosteric control over protein activity</article-title>. <source>Structure</source>. <year>2019</year>; <volume>27</volume>:<fpage>866</fpage>–<lpage>878</lpage>.<pub-id pub-id-type="pmid">30827842</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>K.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Exploring the allosteric territory of protein function</article-title>. <source>J. Phys. Chem. B</source>. <year>2021</year>; <volume>125</volume>:<fpage>3763</fpage>–<lpage>3780</lpage>.<pub-id pub-id-type="pmid">33844527</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Du</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Su</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>H.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Anishchenko</surname><given-names>I.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>D.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J.</given-names></string-name></person-group><article-title>The trRosetta server for fast and accurate protein structure prediction</article-title>. <source>Nat. Protoc.</source><year>2021</year>; <volume>16</volume>:<fpage>5634</fpage>–<lpage>5651</lpage>.<pub-id pub-id-type="pmid">34759384</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jumper</surname><given-names>J.</given-names></string-name>, <string-name><surname>Evans</surname><given-names>R.</given-names></string-name>, <string-name><surname>Pritzel</surname><given-names>A.</given-names></string-name>, <string-name><surname>Green</surname><given-names>T.</given-names></string-name>, <string-name><surname>Figurnov</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ronneberger</surname><given-names>O.</given-names></string-name>, <string-name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bates</surname><given-names>R.</given-names></string-name>, <string-name><surname>Žídek</surname><given-names>A.</given-names></string-name>, <string-name><surname>Potapenko</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Highly accurate protein structure prediction with alphafold</article-title>. <source>Nature</source>. <year>2021</year>; <volume>596</volume>:<fpage>583</fpage>–<lpage>589</lpage>.<pub-id pub-id-type="pmid">34265844</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Varadi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Anyango</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nair</surname><given-names>S.</given-names></string-name>, <string-name><surname>Natassia</surname><given-names>C.</given-names></string-name>, <string-name><surname>Yordanova</surname><given-names>G.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Stroe</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wood</surname><given-names>G.</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D439</fpage>–<lpage>D444</lpage>.<pub-id pub-id-type="pmid">34791371</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mistry</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chuguransky</surname><given-names>S.</given-names></string-name>, <string-name><surname>Williams</surname><given-names>L.</given-names></string-name>, <string-name><surname>Qureshi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Salazar</surname><given-names>G.A.</given-names></string-name>, <string-name><surname>Sonnhammer</surname><given-names>E.L.L.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.E.</given-names></string-name>, <string-name><surname>Paladin</surname><given-names>L.</given-names></string-name>, <string-name><surname>Raj</surname><given-names>S.</given-names></string-name>, <string-name><surname>Richardson</surname><given-names>L.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Pfam: the protein families database in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D412</fpage>–<lpage>D419</lpage>.<pub-id pub-id-type="pmid">33125078</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>W116</fpage>–<lpage>W124</lpage>.<pub-id pub-id-type="pmid">32392302</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Conservation and diversity in allosteric fingerprints of proteins for evolutionary-inspired engineering and design</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167577</fpage>.<pub-id pub-id-type="pmid">35395233</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Booth</surname><given-names>L.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>AlloMAPS: allosteric mutation analysis and polymorphism of signaling database</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D265</fpage>–<lpage>D270</lpage>.<pub-id pub-id-type="pmid">30365033</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Geng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>ASBench: benchmarking sets for allosteric discovery</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>2598</fpage>–<lpage>2600</lpage>.<pub-id pub-id-type="pmid">25810427</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berman</surname><given-names>H.M.</given-names></string-name>, <string-name><surname>Westbrook</surname><given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Gilliland</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>T.N.</given-names></string-name>, <string-name><surname>Weissig</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shindyalov</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Bourne</surname><given-names>P.E.</given-names></string-name></person-group><article-title>The protein data bank</article-title>. <source>Nucleic Acids Res.</source><year>2000</year>; <volume>28</volume>:<fpage>235</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Griep</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hobohm</surname><given-names>U.</given-names></string-name></person-group><article-title>PDBselect 1992-2009 and PDBfilter-select</article-title>. <source>Nucleic Acids Res.</source><year>2010</year>; <volume>38</volume>:<fpage>D318</fpage>–<lpage>D319</lpage>.<pub-id pub-id-type="pmid">19783827</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>On the allosteric effect of nsSNPs and the emerging importance of allosteric polymorphism</article-title>. <source>J. Mol. Biol.</source><year>2019</year>; <volume>431</volume>:<fpage>3933</fpage>–<lpage>3942</lpage>.<pub-id pub-id-type="pmid">31306666</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><collab>UniProt, C.</collab><article-title>UniProt: a worldwide hub of protein knowledge</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D506</fpage>–<lpage>D515</lpage>.<pub-id pub-id-type="pmid">30395287</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Z.</given-names></string-name></person-group><article-title>Basic units of protein structure, folding, and function</article-title>. <source>Prog. Biophys. Mol. Biol.</source><year>2017</year>; <volume>128</volume>:<fpage>85</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">27697476</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeldovich</surname><given-names>K.B.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Shakhnovich</surname><given-names>E.I.</given-names></string-name></person-group><article-title>Physical origins of protein superfamilies</article-title>. <source>J. Mol. Biol.</source><year>2006</year>; <volume>357</volume>:<fpage>1335</fpage>–<lpage>1343</lpage>.<pub-id pub-id-type="pmid">16483605</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mariani</surname><given-names>V.</given-names></string-name>, <string-name><surname>Biasini</surname><given-names>M.</given-names></string-name>, <string-name><surname>Barbato</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schwede</surname><given-names>T.</given-names></string-name></person-group><article-title>lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>2722</fpage>–<lpage>2728</lpage>.<pub-id pub-id-type="pmid">23986568</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Grosberg</surname><given-names>A.Y.</given-names></string-name>, <string-name><surname>Trifonov</surname><given-names>E.N.</given-names></string-name></person-group><article-title>Closed loops of nearly standard size: common basic element of protein structure</article-title>. <source>FEBS Lett.</source><year>2000</year>; <volume>466</volume>:<fpage>283</fpage>–<lpage>286</lpage>.<pub-id pub-id-type="pmid">10682844</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goncearenco</surname><given-names>A.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Protein function from its emergence to diversity in contemporary proteins</article-title>. <source>Phys. Biol.</source><year>2015</year>; <volume>12</volume>:<fpage>045002</fpage>.<pub-id pub-id-type="pmid">26057563</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>C.J.</given-names></string-name></person-group><article-title>Latent drivers’ expand the cancer mutational landscape</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2015</year>; <volume>32</volume>:<fpage>25</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">25661093</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Samsudin</surname><given-names>F.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Bond</surname><given-names>P.J.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Allosteric perspective on the mutability and druggability of the SARS-CoV-2 spike protein</article-title>. <source>Structure</source>. <year>2022</year>; <volume>30</volume>:<fpage>590</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">35063064</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>H.</given-names></string-name>, <string-name><surname>Engkvist</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Olivecrona</surname><given-names>M.</given-names></string-name>, <string-name><surname>Blaschke</surname><given-names>T.</given-names></string-name></person-group><article-title>The rise of deep learning in drug discovery</article-title>. <source>Drug Discov. Today</source>. <year>2018</year>; <volume>23</volume>:<fpage>1241</fpage>–<lpage>1250</lpage>.<pub-id pub-id-type="pmid">29366762</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>LeCun</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Bengio</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hinton</surname><given-names>G.</given-names></string-name></person-group><article-title>Deep learning</article-title>. <source>Nature</source>. <year>2015</year>; <volume>521</volume>:<fpage>436</fpage>–<lpage>444</lpage>.<pub-id pub-id-type="pmid">26017442</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Popova</surname><given-names>M.</given-names></string-name>, <string-name><surname>Isayev</surname><given-names>O.</given-names></string-name>, <string-name><surname>Tropsha</surname><given-names>A.</given-names></string-name></person-group><article-title>Deep reinforcement learning for de novo drug design</article-title>. <source>Sci. Adv.</source><year>2018</year>; <volume>4</volume>:<fpage>eaap7885</fpage>.<pub-id pub-id-type="pmid">30050984</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>AlloSigMA: allosteric signaling and mutation analysis server</article-title>. <source>Bioinformatics</source>. <year>2017</year>; <volume>33</volume>:<fpage>3996</fpage>–<lpage>3998</lpage>.<pub-id pub-id-type="pmid">29106449</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Towards descriptor of elementary functions for protein design</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2019</year>; <volume>58</volume>:<fpage>159</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">31352188</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Boyken</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>D.</given-names></string-name></person-group><article-title>The coming of age of de novo protein design</article-title>. <source>Nature</source>. <year>2016</year>; <volume>537</volume>:<fpage>320</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">27629638</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khersonsky</surname><given-names>O.</given-names></string-name>, <string-name><surname>Fleishman</surname><given-names>S.J.</given-names></string-name></person-group><article-title>Incorporating an allosteric regulatory site in an antibody through backbone design</article-title>. <source>Protein Sci.</source><year>2017</year>; <volume>26</volume>:<fpage>807</fpage>–<lpage>813</lpage>.<pub-id pub-id-type="pmid">28142198</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lechner</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ferruz</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hocker</surname><given-names>B.</given-names></string-name></person-group><article-title>Strategies for designing non-natural enzymes and binders</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2018</year>; <volume>47</volume>:<fpage>67</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">30248579</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dang</surname><given-names>C.V.</given-names></string-name>, <string-name><surname>Reddy</surname><given-names>E.P.</given-names></string-name>, <string-name><surname>Shokat</surname><given-names>K.M.</given-names></string-name>, <string-name><surname>Soucek</surname><given-names>L.</given-names></string-name></person-group><article-title>Drugging the ‘undruggable’ cancer targets</article-title>. <source>Nat. Rev. Cancer</source>. <year>2017</year>; <volume>17</volume>:<fpage>502</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">28643779</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazo</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Sharlow</surname><given-names>E.R.</given-names></string-name></person-group><article-title>Drugging undruggable molecular cancer targets</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source><year>2016</year>; <volume>56</volume>:<fpage>23</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">26527069</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825619</article-id>
    <article-id pub-id-type="pmid">36169226</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac828</article-id>
    <article-id pub-id-type="publisher-id">gkac828</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>AlloMAPS 2: allosteric fingerprints of the AlphaFold and Pfam-trRosetta predicted structures for engineering and design</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Tan</surname>
          <given-names>Zhen Wah</given-names>
        </name>
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tee</surname>
          <given-names>Wei-Ven</given-names>
        </name>
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Guarnera</surname>
          <given-names>Enrico</given-names>
        </name>
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3315-8483</contrib-id>
        <name>
          <surname>Berezovsky</surname>
          <given-names>Igor N</given-names>
        </name>
        <!--igorb@bii.a-star.edu.sg-->
        <aff><institution>Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR)</institution>, 30 Biopolis Street, #07-01, Matrix, <addr-line>138671</addr-line>, <country country="SG">Singapore</country></aff>
        <aff><institution>Department of Biological Sciences (DBS), National University of Singapore (NUS)</institution>, 8 Medical Drive, <addr-line>117579</addr-line>, <country country="SG">Singapore</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +65 6478 8269; Fax: +65 6478 9047; Email: <email>igorb@bii.a-star.edu.sg</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-09-28">
      <day>28</day>
      <month>9</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>28</day>
      <month>9</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D345</fpage>
    <lpage>D351</lpage>
    <history>
      <date date-type="accepted">
        <day>15</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>26</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>25</day>
        <month>7</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac828.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>AlloMAPS 2 is an update of the Allosteric Mutation Analysis and Polymorphism of Signalling database, which contains data on allosteric communication obtained for predicted structures in the AlphaFold database (AFDB) and trRosetta-predicted Pfam domains. The data update contains Allosteric Signalling Maps (ASMs) and Allosteric Probing Maps (APMs) quantifying allosteric effects of mutations and of small probe binding, respectively. To ensure quality of the ASMs and APMs, we performed careful and accurate selection of protein sets containing high-quality predicted structures in both databases for each organism/structure, and the data is available for browsing and download. The data for remaining structures are available for download and should be used at user's discretion and responsibility. We believe these massive data can facilitate both diagnostics and drug design within the precision medicine paradigm. Specifically, it can be instrumental in the analysis of allosteric effects of pathological and rescue mutations, providing starting points for fragment-based design of allosteric effectors. The exhaustive character of allosteric signalling and probing fingerprints will be also useful in future developments of corresponding machine learning applications. The database is freely available at: <ext-link xlink:href="http://allomaps.bii.a-star.edu.sg" ext-link-type="uri">http://allomaps.bii.a-star.edu.sg</ext-link>.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>AlloMAPS update: allosteric fingerprints of proteins in AlphaFold database and trRosetta-predicted Pfam domains.</p>
          </caption>
          <graphic xlink:href="gkac828figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Agency for Science, Technology and Research</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001348</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>C210812031</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC2">
    <title>INTRODUCTION</title>
    <p>Despite constantly growing interest in biomedical implications of allostery in general (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>) and in design of allosteric effectors in particular (<xref rid="B3" ref-type="bibr">3–6</xref>), there is only a handful number of clinically approved allosteric drugs most of which were discovered serendipitously (<xref rid="B4" ref-type="bibr">4</xref>). Moreover, it is increasingly recognized that well-established principles and protocols in the screening of ligand libraries against traditional drug targets and their binding sites are not optimal for the identification and design of allosterically acting medicines (<xref rid="B7" ref-type="bibr">7</xref>). The quest for allosteric drugs should be based, therefore, on completely different principles determined by distinct characteristics of allosteric sites and effectors (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>) and by the structural dynamics-based perturbative nature of allostery (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). Specifically, it was suggested that this procedure should start from the search of latent (<xref rid="B11" ref-type="bibr">11</xref>) or design of new non-natural allosteric sites (<xref rid="B12" ref-type="bibr">12</xref>) followed by mutual design and adjustments of the allosteric ligand-site pair in order to achieve required effects (<xref rid="B7" ref-type="bibr">7</xref>). The proposed framework is based on the Structure-Based Statistical Mechanical Model of Allostery (SBSMMA, (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B13" ref-type="bibr">13</xref>)), which provides quantification of allosteric signalling with per-residue resolution, allowing, thus, to tune ligand-site interactions in order to obtain desired allosteric effects (<xref rid="B14" ref-type="bibr">14</xref>). Acknowledging the omnipresence of allostery (<xref rid="B6" ref-type="bibr">6</xref>) and advantages of prospected allosteric drugs (<xref rid="B4" ref-type="bibr">4–6</xref>), which are supported by recent progress in quantitative description of allostery, one may conclude that practically any disease-causing protein can be considered as a target for allosteric drug development (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B7" ref-type="bibr">7</xref>). Recent progress in AI-based structure predictions (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>) delivered the structures of a large number of potential yet unexplored drug targets with uncharacterized allosteric signalling. The goal of this update is to provide a comprehensive information on allosteric communication in predicted structures from the AlphaFold (<xref rid="B17" ref-type="bibr">17</xref>) and Pfam (<xref rid="B18" ref-type="bibr">18</xref>) databases. In addition to Allosteric Signalling Maps (ASMs), which exhaustively describe the signalling in per-residue approximation and allosteric effects of mutations, we computed the Allosteric Probing Maps (APMs) quantifying the allosteric effects of small probe binding, which can be used in fragment-based design of allosteric effectors (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B19" ref-type="bibr">19</xref>). We provide corresponding information for 12 model organism proteomes and 14 proteomes of various pathogens involved in global health issues presented in AlphaFold protein structure database (<xref rid="B17" ref-type="bibr">17</xref>) and for the set of trRosetta-predicted (<xref rid="B15" ref-type="bibr">15</xref>) Pfam domains (<xref rid="B18" ref-type="bibr">18</xref>).</p>
  </sec>
  <sec sec-type="methods" id="SEC3">
    <title>THEORETICAL BACKGROUND AND COMPUTATIONAL METHODS</title>
    <p>We quantified allosteric communication on the predicted structures using the benchmarked Structure-Based Statistical Mechanical Model of Allostery (SBSMMA, (<xref rid="B9" ref-type="bibr">9</xref>)). The model outputs are presented in form of allosteric signalling/probing maps (ASM/APMs, (<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B19" ref-type="bibr">19</xref>)), which show changes in per-residue free energy in response to signals caused by a perturbation: single-residue mutations or small-probe binding to three-residue segments in case of ASM and APM, respectively. The per-residue free energy difference (kcal/mol) between the native <inline-formula><tex-math id="M0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( 0 )$\end{document}</tex-math></inline-formula> and perturbed <inline-formula><tex-math id="M0001a" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( P )$\end{document}</tex-math></inline-formula> states is estimated for each residue <inline-formula><tex-math id="M0002" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>, <inline-formula><tex-math id="M0003" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta \ g_i^{( P )} = \frac{1}{2}\ {k}_BT\mathop \sum \limits_\mu \ln \frac{{\varepsilon _{\mu ,i}^{( P )}}}{{\varepsilon _{\mu ,i}^{( 0 )}}},$\end{document}</tex-math></inline-formula> which depends exclusively on the parameters <inline-formula><tex-math id="M0004" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\varepsilon _{\mu ,i}$\end{document}</tex-math></inline-formula> that characterize the native <inline-formula><tex-math id="M0005" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( 0 )$\end{document}</tex-math></inline-formula> and perturbed <inline-formula><tex-math id="M0006" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$( P )$\end{document}</tex-math></inline-formula> protein conformational ensembles. Briefly, the free energy <inline-formula><tex-math id="M0007" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${g}_i = \ - {k}_BT\ln {z}_i$\end{document}</tex-math></inline-formula> is obtained from the per-residue partition function <inline-formula><tex-math id="M0008" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${z}_i = \mathop \prod \limits_\mu {( {\pi 2{k}_BT/{\varepsilon }_{\mu ,i}} )}^{1/2}$\end{document}</tex-math></inline-formula>, which, in turn, is a result of the integration of the allosteric potential over all possible displacements of neighbors of the residue <inline-formula><tex-math id="M0009" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>. The allosteric potential <inline-formula><tex-math id="M00010" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${U}_i\ ( \sigma ) = \ 1/2\mathop \sum \limits_\mu {\varepsilon }_{\mu ,i}\sigma _\mu ^2$\end{document}</tex-math></inline-formula> evaluates the effect of a perturbation on a residue <italic toggle="yes">i</italic> as the elastic work (the implementation of SBSMMA used here is based on a Cα harmonic model of proteins) exerted on <italic toggle="yes">i</italic> due to changes in the displacements of surrounding residues <italic toggle="yes">j</italic> caused by normal modes <inline-formula><tex-math id="M00011" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${{\boldsymbol{e}}}_\mu$\end{document}</tex-math></inline-formula>, where <inline-formula><tex-math id="M00012" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\varepsilon }_{\mu ,i} = \mathop \sum \limits_j {| {{{\boldsymbol{e}}}_{\mu ,i} - {{\boldsymbol{e}}}_{\mu ,j}} |}^2$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00013" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\sigma \ = ( {{\sigma }_1, \ldots ,\ {\sigma }_\mu ,\ \ldots } )$\end{document}</tex-math></inline-formula> is a set of Gaussian distributed amplitudes with variance 1/<inline-formula><tex-math id="M00014" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\varepsilon }_{\mu ,i}$\end{document}</tex-math></inline-formula> (see for details (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>)). We evaluate the allosteric modulation as a deviation of the obtained free energy difference from its mean value over the protein chain, eliminating thus the background allosteric signalling: <inline-formula><tex-math id="M00015" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( P )} = \ {\rm{\Delta }}g_i^{( P )} - {\langle {\rm{\Delta }}g_i^{( P )}\rangle }_{Chain/Protein}$\end{document}</tex-math></inline-formula>. Allosteric modulation close to zero indicates that signalling to the residue/site of interest is similar to the background effect on the whole chain/protein. In terms of mutations, we modelled the effect of UP (<inline-formula><tex-math id="M00016" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m \uparrow$\end{document}</tex-math></inline-formula>) mutations, which represent a substitution of residue <inline-formula><tex-math id="M00017" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula> to the bulkiest ones (for example Phe or Trp), and the resultant free energy change at responding residue <inline-formula><tex-math id="M00018" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula> is expressed as <inline-formula><tex-math id="M00019" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( {m \uparrow } )}$\end{document}</tex-math></inline-formula>. Similarly, DOWN (<inline-formula><tex-math id="M00020" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m \downarrow$\end{document}</tex-math></inline-formula>) mutations model the opposite conversion of a residue <inline-formula><tex-math id="M00021" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula> to the smallest amino acid (Gly-like), and the effect on residue <inline-formula><tex-math id="M00022" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula> is expressed as <inline-formula><tex-math id="M00023" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( {m \downarrow } )}$\end{document}</tex-math></inline-formula>. The allosteric modulation range (kcal/mol) on responding residue <inline-formula><tex-math id="M00024" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula><inline-formula><tex-math id="M00025" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta \ }}h_i^{( {m \downarrow \uparrow } )} = \ {\rm{\Delta }}h_i^{( {m \uparrow } )} - {\rm{\Delta }}h_i^{( {m \downarrow } )}$\end{document}</tex-math></inline-formula> is a measure of the overall allosteric effect on residue <inline-formula><tex-math id="M00026" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula> upon a substitution of the smallest amino acid by the largest one at residue position <inline-formula><tex-math id="M00027" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula>, providing a generic description of the maximal signalling strength from position <inline-formula><tex-math id="M00028" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$m$\end{document}</tex-math></inline-formula> to <inline-formula><tex-math id="M00029" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>. For amino acid changes in the opposite direction, namely from the largest to the smallest residues, the modulation range is <inline-formula><tex-math id="M00030" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta \ h_i^{( {m \uparrow \downarrow } )} = \ - \Delta h_i^{( {m \downarrow \uparrow } )}$\end{document}</tex-math></inline-formula>. Since the signal obtained upon conversion between the largest and the smallest amino acids is the same in absolute value regardless of the direction of the substitution, it serves as an indicator of the dynamic range of the allosteric signal that can be obtained upon mutations of a considered position in the protein sequence/structure. Exhaustive quantification of signalling for all pairwise residue positions is represented in the ASM matrix plot (Figure <xref rid="F1" ref-type="fig">1</xref>). The ASM reveals distant residues/protein regions that are allosterically connected with strong positive or negative signalling, which might indicate conformational changes or stabilization in the affected residues/regions, respectively. On the other hand, to understand and explore the effect of ligand binding to different parts of a protein chain, we exhaustively simulate the binding of a small probe to every consecutive three-residue segment along a protein chain (see (<xref rid="B14" ref-type="bibr">14</xref>) for technical details). The effect of a probe binding on every residue <inline-formula><tex-math id="M00031" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$i$\end{document}</tex-math></inline-formula>, <inline-formula><tex-math id="M00032" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\rm{\Delta }}h_i^{( {Probe} )},$\end{document}</tex-math></inline-formula> is represented in the APM matrix plot (Figure <xref rid="F1" ref-type="fig">1</xref>, for details of APM calculation see (<xref rid="B14" ref-type="bibr">14</xref>)). The ASM/APM matrices are presented here in the form of allosteric fingerprints, in which the signalling between proximal residues (see (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B20" ref-type="bibr">20</xref>) for explanations of proximity according to an operational definition of allosteric distances) and/or those with negligible modulation are color-coded (in blue-green), allowing the user to focus on the relevant and strong allosteric communication.</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>Flowchart of the datasets added to the AlloMAPS 2 database and its updated features. First row: selection of the dataset, AlphaFold or Pfam-trRosetta. Second row: selection of the organism (left panel) in AlphaFold dataset and of the protein (in both datasets). Third row: description of the protein (left) and optional selection of parts of ASM/APM in case of large structures with more than 1200 residues. Bottom row: selected part of ASM/APM (left/right) and structure (center) of considered here Splicing factor 3B subunit 3.</p>
      </caption>
      <graphic xlink:href="gkac828fig1" position="float"/>
    </fig>
  </sec>
  <sec id="SEC4">
    <title>DESCRIPTION OF THE DATABASE UPDATE</title>
    <p>The original database (<xref rid="B21" ref-type="bibr">21</xref>) contained data on allosteric signalling in more than 2000 proteins and protein chains grouped in three sets: (i) ‘Allosteric proteins’ with the data on allosteric regulation in 48 proteins documented on the basis of experimental works (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B12" ref-type="bibr">12</xref>) originally published in (<xref rid="B22" ref-type="bibr">22</xref>); (ii) ‘PDBselect chains’ set of 1908 protein chains contains representative structures with low sequence identity (less than 25%) providing a ‘list of representative protein chains with low mutual sequence identity selected from the protein data bank (PDB, (<xref rid="B23" ref-type="bibr">23</xref>)), which enables unbiased statistics’ (<xref rid="B24" ref-type="bibr">24</xref>); (iii) ‘Allosteric polymorphism’ set with 33 proteins (<xref rid="B21" ref-type="bibr">21</xref>) with multiple (more than 50 in each protein) known pathology-related SNPs originally obtained in (<xref rid="B25" ref-type="bibr">25</xref>) based on the UniprotKB/Swiss-Prot (<xref rid="B26" ref-type="bibr">26</xref>) Humsavar database (version 2017_09; current version is available at: <ext-link xlink:href="https://ftp.uniprot.org/pub/databases/uniprot/current_release/knowledgebase/complete/docs/humsavar" ext-link-type="uri">https://ftp.uniprot.org/pub/databases/uniprot/current_release/knowledgebase/complete/docs/humsavar</ext-link>) containing all missense variants annotated in human entries.</p>
    <p>The current update includes high-throughput data on allosteric signalling and effects of probing in the predicted structures from the AlphaFold (<xref rid="B16" ref-type="bibr">16</xref>) protein structure database (<xref rid="B17" ref-type="bibr">17</xref>) and the trRosetta (<xref rid="B15" ref-type="bibr">15</xref>) predicted set of Pfam (<xref rid="B18" ref-type="bibr">18</xref>) domains. The original collections of structures were filtered in order to select only structures with sizes larger than typical size of protein domains/folds (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>) and with sufficient quality of predictions (see Materials and Methods for the description of filtering procedure). Table <xref rid="tbl1" ref-type="table">1</xref> contains a list of organisms presented in the AlphaFold database with the total number of initial protein entries available for download and the number of high-quality structures available for browsing in AlloMAPS 2. Remaining structures not satisfying the filtering criteria are available through the search using their accession code listed in downloadable complete lists of proteomes (see online Tutorial and Materials and Methods for details).</p>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>List of AlphaFold proteomes included in the AlloMAPS 2 database update. Quality filters were applied to the predicted structures, requiring that low-confidence residues (LCRs) constitute only a small fraction of the structure and do not form long consecutive segments. Structures with low-confidence signal peptides were also excluded. The Browse function for the database focuses on reasonably large structures with more than 100 residues, yielding about 50 000 proteins in all proteomes presented in this table</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Organism name</th>
            <th rowspan="1" colspan="1">AlphaFold entries with full structure</th>
            <th rowspan="1" colspan="1">Selected entries for browsing</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Homo sapiens</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">20 296</td>
            <td rowspan="1" colspan="1">4073</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Mus musculus</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">21 615</td>
            <td rowspan="1" colspan="1">4989</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Drosophila melanogaster</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">13 458</td>
            <td rowspan="1" colspan="1">2823</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Danio rerio</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">24 664</td>
            <td rowspan="1" colspan="1">5032</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Candida albicans</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5974</td>
            <td rowspan="1" colspan="1">1598</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Caenorhabditis elegans</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">19 694</td>
            <td rowspan="1" colspan="1">4866</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Arabidopsis thaliana</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">27 434</td>
            <td rowspan="1" colspan="1">5126</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Oryza sativa</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">43 649</td>
            <td rowspan="1" colspan="1">5221</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Escherichia coli</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">4363</td>
            <td rowspan="1" colspan="1">2979</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Saccharomyces cerevisiae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">6040</td>
            <td rowspan="1" colspan="1">1540</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Schizosaccharomyces pombe</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5128</td>
            <td rowspan="1" colspan="1">1515</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Methanococcus jannaschii</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1773</td>
            <td rowspan="1" colspan="1">1305</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Staphylococcus aureus</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2887</td>
            <td rowspan="1" colspan="1">1874</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Plasmodium falciparum</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5187</td>
            <td rowspan="1" colspan="1">683</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Pseudomonas aeruginosa</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5556</td>
            <td rowspan="1" colspan="1">3832</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Helicobacter pylori</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1538</td>
            <td rowspan="1" colspan="1">939</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Mycobacterium tuberculosis</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">3988</td>
            <td rowspan="1" colspan="1">2347</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Shigella dysentriae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">3893</td>
            <td rowspan="1" colspan="1">2469</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Campylobacter jejuni</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1620</td>
            <td rowspan="1" colspan="1">1217</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Enterococcus faecium</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2823</td>
            <td rowspan="1" colspan="1">2504</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Salmonella typhimurium</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">4526</td>
            <td rowspan="1" colspan="1">3101</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Haemophilus pneumoniae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1662</td>
            <td rowspan="1" colspan="1">1180</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Streptococcus pneumoniae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2030</td>
            <td rowspan="1" colspan="1">1177</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Kiebsiella pneumoniae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">5727</td>
            <td rowspan="1" colspan="1">3784</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Neisseria gonorrhoeae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">2106</td>
            <td rowspan="1" colspan="1">1246</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>
                <italic toggle="yes">Mycobacterium leprae</italic>
              </bold>
            </td>
            <td rowspan="1" colspan="1">1602</td>
            <td rowspan="1" colspan="1">875</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </sec>
  <sec sec-type="materials|methods" id="SEC5">
    <title>MATERIALS AND METHODS</title>
    <p>The predicted structures of 12 key model organisms and 14 pathogens from the AlphaFold protein structure database (<ext-link xlink:href="https://alphafold.ebi.ac.uk/download" ext-link-type="uri">https://alphafold.ebi.ac.uk/download</ext-link>, (<xref rid="B17" ref-type="bibr">17</xref>)) and of 6370 protein families from the Pfam database (<ext-link xlink:href="http://ftp.ebi.ac.uk/pub/databases/Pfam/releases/Pfam33.1/structure_models/" ext-link-type="uri">http://ftp.ebi.ac.uk/pub/databases/Pfam/releases/Pfam33.1/structure_models/</ext-link>, (<xref rid="B18" ref-type="bibr">18</xref>)) were filtered in order to focus on high-quality structures contained in these large datasets. Confidence of residue-level structures were estimated in AlphaFold (<xref rid="B17" ref-type="bibr">17</xref>) using a measure called pLDDT, which is based on the lDDT (local Distance Difference Test) metric (<xref rid="B29" ref-type="bibr">29</xref>) obtained by comparing pairwise distances of C-alpha atoms between predicted and existing reference structures. First, in both AlphaFold and trRosetta predictions, a residue having pLDDT score lower than 70 (equivalently, lDDT score lower than 0.7) indicates low confidence in the prediction. Hence, a structure prediction of high quality should have few or no low-confidence residues (LCRs), and should not have long continuous stretches of low-confidence residues. In alignment with the original AlphaFold publication (<xref rid="B17" ref-type="bibr">17</xref>), residues with scores pLDDT &lt;70 are considered low-confidence residues (LCRs). To this end, we required that the percentage of LCRs in each structure (listed under the column lcr_perc in the downloadable table of structures) be lower than a given threshold (10% for prokaryotes and 20% for eukaryotes), and that the longest continuous stretch of LCRs (lcr_length) be shorter than a given threshold (15 residues for prokaryotes, 25 for eukaryotes)—we set this limit on the basis of polymer nature of protein backbone determining the size of protein chain returns known as closed loops (<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B31" ref-type="bibr">31</xref>). We adopted looser requirements for eukaryotes due to the presence of relatively larger unstructured or disordered regions in eukaryotic proteins (<xref rid="B27" ref-type="bibr">27</xref>). To exclude structures containing low-confidence signal peptides, we further required that the first 20 residues from the N-terminus are not all LCRs. Finally, we considered only structures that are larger than 50 residues in size, guaranteeing at least the protein fold size for considered structures (<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>). Corresponding numbers of proteins remaining after selection according to above criteria are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>. The Browse function shows only structures with &gt;100 residues, yielding more than 50 000 high-quality structures (see Table <xref rid="tbl1" ref-type="table">1</xref>) with sizes exceeding the minimal size of protein domain/fold (<xref rid="B28" ref-type="bibr">28</xref>). Other structures can be accessed through the search function using their accession code listed in the downloadable complete lists of proteomes (see online Tutorial for details).</p>
  </sec>
  <sec id="SEC6">
    <title>ORGANIZATION OF THE NEW DATASETS, THEIR NAVIGATION AND USAGE</title>
    <p>Figure <xref rid="F1" ref-type="fig">1</xref> shows a flowchart navigating through the updated parts of the database, as well as generically implemented new features. To browse AlphaFold structures, users can first select a proteome of interest. Clicking on the AlphaFold panel (shown in Figure <xref rid="F1" ref-type="fig">1</xref> along with the Pfam-trRosetta starting panel) in the AlloMAPS home page brings users to the list of organisms with AlphaFold proteomes available in the database. Selecting an organism of interest (Figure <xref rid="F1" ref-type="fig">1</xref>, second row, left panel) generates a list of predicted structures satisfying our quality control criteria and passing the filtering procedure (see Materials and Methods), which enables the users to identify a structure of interest. The list of proteins (Figure <xref rid="F1" ref-type="fig">1</xref>, second row, right panel) starts from structures with the smallest proportion of low-confidence residues. Examples of top25 entries in each organism are presented in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>. Selecting a given structure brings the user to the interactive data dashboard schematically shown in the third level (left panel), where further information about the protein is provided, with links to relevant external resources (for example, AlphaFold and Uniprot).</p>
    <p>Accessing the structure of interest, the users can study how structural perturbations in different parts of the protein can affect distant regions allosterically. In the original version of AlloMAPS, users were able to study the effect of individual mutations by selecting these residues on the ‘Residues: Binding/Mutation’ panel, and also visualize the allosteric signalling map (ASM) as a matrix plot in the corresponding panel. These features have been retained, and we have also added the pre-computed allosteric probing map (APM) for each structure in this update. Furthermore, we have updated the matrix view of the allosteric signalling/probing maps using allosteric fingerprints, masking the effects due to proximal regions and/or weak signalling. Large structures (above 1200 residues) may be studied by zooming into selected, smaller regions of interest (Figure 1, third row, right panel). In case of using the Pfam-trRosetta dataset, the user starts from the corresponding panel on the AlloMAPS homepage, which will open the page with a list of structures, similar to the one for AlphaFold proteins (second row, right panel). Some tasks may require additional and/or preliminary analysis: as an example, oligomerization will definitely originate additional signalling, which will be taking place between protomers and may affect to some extent the original signalling in individual protomers. Therefore, while signalling in protomers can be obtained from the presented database, in order to analyze a complete picture of allosteric signalling in oligomers, it will be necessary to obtain accurate structures of oligomers as an input for the AlloSigMA server (<xref rid="B19" ref-type="bibr">19</xref>) to compute ASMs/APMs. Noteworthy, some low-quality AlphaFold predictions may require special treatments. For example, in case of multi-chain and/or oligomeric proteins the AlphaFold predictions should be performed first for individual chains/protomers followed by the assembly into the final structure.</p>
    <p>Figure <xref rid="F1" ref-type="fig">1</xref> illustrates the example of splicing factor 3B subunit 3, consisting of 1217 amino acid residues, of which first 800 residues were selected (third row, right panel) for building the ASM and APM fingerprints. We would like to specifically emphasize on the appearance of the APM fingerprint. The APM fingerprint (bottom row, right panel) contains, unlike the corresponding ASM’s fingerprint (bottom row, left panel), more areas featuring negligible signalling strength and at short distances, which are filtered out from the original APM (these areas are blue-green masked in the fingerprint). Nevertheless, it is a meaningful result indicating that only a limited number of places can be targeted in order to obtain a strong allosteric signal originated by the probe binding. Another technical improvement we have implemented in this update is the ability to visualize large structures that were previously inaccessible due to memory constraints: for all structures above 1200 residues in size, an extra panel is included to enable users to zoom in on different, smaller regions to examine signalling data on applied perturbation and responses.</p>
  </sec>
  <sec sec-type="conclusions" id="SEC7">
    <title>CONCLUSIONS</title>
    <p>Constantly improving resolution of experimental techniques, such as X-ray crystallography, NMR, and cryoEM and their transformation into high-throughput approaches have provided wealth of experimental data, on protein structures and sequences, in particular. It has allowed, in turn, to use the power of machine learning for predicting protein structures that are difficult to obtain via experiments (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>). Advantages of allosteric medicines (<xref rid="B4" ref-type="bibr">4–7</xref>) over traditional orthosteric ones call for their development targeting established and new drug targets. At the same time, observations on mutations (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B25" ref-type="bibr">25</xref>) triggering different pathologies via allosteric signalling point to the need of their characterization and consideration in diagnostics (<xref rid="B6" ref-type="bibr">6</xref>). The significantly expanded array of potential drug targets provided by the AI-based predictions of protein structures (<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>) is especially important for answering the quests for precision/personalized medicine, motivating us to perform this update of the AlloMAPS database. We provide here about 50 000 fingerprints of Allosteric Signalling and Probing Maps (ASMs/APMs) for newly predicted high-quality structures. This update allows to expand the analysis of allosteric communication from the effects of ligand binding and mutations to engineering and design of allosteric signalling (<xref rid="B20" ref-type="bibr">20</xref>) in newly predicted structures, as well as to target them with newly developed allosteric effectors (<xref rid="B7" ref-type="bibr">7</xref>). Specifically, the ASM fingerprints will facilitate diagnostics of different pathologies, helping to predict allosteric effects of mutations and their combinations, and analyzing their role in expansion of cancer landscapes (<xref rid="B32" ref-type="bibr">32</xref>) and triggering other diseases (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>). One of the recent examples of using ASMs as a diagnostic tool demonstrated successful prediction of distant mutations (many of which are associated with variants of concern including the Omicron variant) that might affect the dynamics of the receptor-binding domain of the SARS-CoV-2 Spike protein (<xref rid="B33" ref-type="bibr">33</xref>). The APM fingerprints will be useful in fragment-based design of allosteric drug candidates. The comprehensive nature of ASM/APM fingerprints available in the AlloMAPS database along with extensivity of free energy accounting for allosteric effects in SBSMMA allows one to use these data as an input for future machine learning approaches (<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B35" ref-type="bibr">35</xref>) on diagnostics and drug design (<xref rid="B36" ref-type="bibr">36</xref>).</p>
    <p>The outlook on future work presents several promising research directions that can be explored with the SBSMMA-based (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B12" ref-type="bibr">12–14</xref>) computational suite comprised of the AlloSigMA (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B37" ref-type="bibr">37</xref>) web-server and the AlloMAPS database, as well as corresponding requirements for their further developments. The high-throughput data presented in this update provides an overall picture of allosteric signalling in predicted structures of proteins important in biomedical and biotechnological applications, which can serve as a starting point in diagnostics and engineering/design efforts involving these proteins. Further steps in these efforts may require more accurate consideration of allosteric effects, which can be achieved within the SBSMMA framework by replacing the input normal modes obtained from a C<sub>α</sub> harmonic model of the protein backbone with the principal components of the covariance matrix obtained in atomistic MD simulations of corresponding structures (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B7" ref-type="bibr">7</xref>). The MD-based approach comes, however, at the expense of increased computing time, making it necessary, for practical purposes, to combine data obtained in atomistic simulations with the massive coarse-grained one presented in AlloMAPS. The high-throughput data would also be instrumental for validation and calibration of computational predictions in conjunction with experimental assays (<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B7" ref-type="bibr">7</xref>), such as deep mutational scanning and fragment-based screening. The capability of artificial intelligence (AI) algorithms (<xref rid="B34" ref-type="bibr">34–36</xref>) in performing feature extraction from low-level data representation with non-obvious hierarchical connectivity and to model complex nonlinear input-output relationships can be utilized on the basis of these data. All the above will provide an opportunity to include allosteric regulation as an integral part of protein design procedures (<xref rid="B38" ref-type="bibr">38–41</xref>) and to improve protocols for design of allosteric drugs (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B7" ref-type="bibr">7</xref>), which, in turn, will allow to tackle challenging tasks of targeting so-called undruggable targets (<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>) and regulating multiscale cellular signalling.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC8">
    <title>DATA AVAILABILITY</title>
    <p>The database is freely available at: <ext-link xlink:href="http://allomaps.bii.a-star.edu.sg" ext-link-type="uri">http://allomaps.bii.a-star.edu.sg</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac828_Supplemental_Files</label>
      <media xlink:href="gkac828_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC9">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac828#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC10">
    <title>FUNDING</title>
    <p>Agency for Science, Technology, and Research (A*STAR) under the Career Development Fund [C210812031 to W.V.T.]. Funding for open access charges: Biomedical Research Council, Agency for Science, Technology, and Research (A*STAR).</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Enrico Guarnera, Global Analytical Pharmaceutical Science and Innovation, Merck KGaA, Via Luigi Einaudi, 11, Guidonia Montecelio, 00012 Rome, Italy.</p>
  </notes>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wodak</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Paci</surname><given-names>E.</given-names></string-name>, <string-name><surname>Dokholyan</surname><given-names>N.V.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Horovitz</surname><given-names>A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hilser</surname><given-names>V.J.</given-names></string-name>, <string-name><surname>Bahar</surname><given-names>I.</given-names></string-name>, <string-name><surname>Karanicolas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Stock</surname><given-names>G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Allostery in its many disguises: from theory to applications</article-title>. <source>Structure</source>. <year>2019</year>; <volume>27</volume>:<fpage>566</fpage>–<lpage>578</lpage>.<pub-id pub-id-type="pmid">30744993</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name></person-group><article-title>Multiscale allostery: basic mechanisms and versatility in diagnostics and drug design</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167751</fpage>.<pub-id pub-id-type="pmid">35863488</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Thermodynamics of allostery paves a way to allosteric drugs</article-title>. <source>Biochim. Biophys. Acta</source>. <year>2013</year>; <volume>1834</volume>:<fpage>830</fpage>–<lpage>835</lpage>.<pub-id pub-id-type="pmid">23376182</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Allosteric drugs and mutations: chances, challenges, and necessity</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2020</year>; <volume>62</volume>:<fpage>149</fpage>–<lpage>157</lpage>.<pub-id pub-id-type="pmid">32062398</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>C.J.</given-names></string-name></person-group><article-title>Allostery in disease and in drug discovery</article-title>. <source>Cell</source>. <year>2013</year>; <volume>153</volume>:<fpage>293</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">23582321</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Maloney</surname><given-names>R.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Jang</surname><given-names>H.</given-names></string-name></person-group><article-title>Allostery: allosteric cancer drivers and innovative allosteric drugs</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167569</fpage>.<pub-id pub-id-type="pmid">35378118</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Learning about allosteric drugs and ways to design them</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <fpage>167692</fpage>.<pub-id pub-id-type="pmid">35738428</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Disorder driven allosteric control of protein activity</article-title>. <source>Curr. Res. Struct. Biol.</source><year>2020</year>; <volume>2</volume>:<fpage>191</fpage>–<lpage>203</lpage>.<pub-id pub-id-type="pmid">34235479</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Structure-Based statistical mechanical model accounts for the causality and energetics of allosteric communication</article-title>. <source>PLoS Comput. Biol.</source><year>2016</year>; <volume>12</volume>:<fpage>e1004678</fpage>.<pub-id pub-id-type="pmid">26939022</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>On the perturbation nature of allostery: sites, mutations, and signal modulation</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2019</year>; <volume>56</volume>:<fpage>18</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">30439587</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Allosteric sites: remote control in regulation of protein activity</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2016</year>; <volume>37</volume>:<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">26562539</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Reversing allosteric communication: from detecting allosteric sites to inducing and tuning targeted allosteric response</article-title>. <source>PLoS Comput. Biol.</source><year>2018</year>; <volume>14</volume>:<fpage>e1006228</fpage>.<pub-id pub-id-type="pmid">29912863</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Toward comprehensive allosteric control over protein activity</article-title>. <source>Structure</source>. <year>2019</year>; <volume>27</volume>:<fpage>866</fpage>–<lpage>878</lpage>.<pub-id pub-id-type="pmid">30827842</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>K.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Exploring the allosteric territory of protein function</article-title>. <source>J. Phys. Chem. B</source>. <year>2021</year>; <volume>125</volume>:<fpage>3763</fpage>–<lpage>3780</lpage>.<pub-id pub-id-type="pmid">33844527</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Du</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Su</surname><given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>H.</given-names></string-name>, <string-name><surname>Peng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Anishchenko</surname><given-names>I.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>D.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J.</given-names></string-name></person-group><article-title>The trRosetta server for fast and accurate protein structure prediction</article-title>. <source>Nat. Protoc.</source><year>2021</year>; <volume>16</volume>:<fpage>5634</fpage>–<lpage>5651</lpage>.<pub-id pub-id-type="pmid">34759384</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jumper</surname><given-names>J.</given-names></string-name>, <string-name><surname>Evans</surname><given-names>R.</given-names></string-name>, <string-name><surname>Pritzel</surname><given-names>A.</given-names></string-name>, <string-name><surname>Green</surname><given-names>T.</given-names></string-name>, <string-name><surname>Figurnov</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ronneberger</surname><given-names>O.</given-names></string-name>, <string-name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bates</surname><given-names>R.</given-names></string-name>, <string-name><surname>Žídek</surname><given-names>A.</given-names></string-name>, <string-name><surname>Potapenko</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Highly accurate protein structure prediction with alphafold</article-title>. <source>Nature</source>. <year>2021</year>; <volume>596</volume>:<fpage>583</fpage>–<lpage>589</lpage>.<pub-id pub-id-type="pmid">34265844</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Varadi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Anyango</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nair</surname><given-names>S.</given-names></string-name>, <string-name><surname>Natassia</surname><given-names>C.</given-names></string-name>, <string-name><surname>Yordanova</surname><given-names>G.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Stroe</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wood</surname><given-names>G.</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D439</fpage>–<lpage>D444</lpage>.<pub-id pub-id-type="pmid">34791371</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mistry</surname><given-names>J.</given-names></string-name>, <string-name><surname>Chuguransky</surname><given-names>S.</given-names></string-name>, <string-name><surname>Williams</surname><given-names>L.</given-names></string-name>, <string-name><surname>Qureshi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Salazar</surname><given-names>G.A.</given-names></string-name>, <string-name><surname>Sonnhammer</surname><given-names>E.L.L.</given-names></string-name>, <string-name><surname>Tosatto</surname><given-names>S.C.E.</given-names></string-name>, <string-name><surname>Paladin</surname><given-names>L.</given-names></string-name>, <string-name><surname>Raj</surname><given-names>S.</given-names></string-name>, <string-name><surname>Richardson</surname><given-names>L.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Pfam: the protein families database in 2021</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D412</fpage>–<lpage>D419</lpage>.<pub-id pub-id-type="pmid">33125078</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>AlloSigMA 2: paving the way to designing allosteric effectors and to exploring allosteric effects of mutations</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>W116</fpage>–<lpage>W124</lpage>.<pub-id pub-id-type="pmid">32392302</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Conservation and diversity in allosteric fingerprints of proteins for evolutionary-inspired engineering and design</article-title>. <source>J. Mol. Biol.</source><year>2022</year>; <volume>434</volume>:<fpage>167577</fpage>.<pub-id pub-id-type="pmid">35395233</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Booth</surname><given-names>L.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>AlloMAPS: allosteric mutation analysis and polymorphism of signaling database</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D265</fpage>–<lpage>D270</lpage>.<pub-id pub-id-type="pmid">30365033</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>G.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Geng</surname><given-names>L.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name></person-group><article-title>ASBench: benchmarking sets for allosteric discovery</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>2598</fpage>–<lpage>2600</lpage>.<pub-id pub-id-type="pmid">25810427</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berman</surname><given-names>H.M.</given-names></string-name>, <string-name><surname>Westbrook</surname><given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Gilliland</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bhat</surname><given-names>T.N.</given-names></string-name>, <string-name><surname>Weissig</surname><given-names>H.</given-names></string-name>, <string-name><surname>Shindyalov</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Bourne</surname><given-names>P.E.</given-names></string-name></person-group><article-title>The protein data bank</article-title>. <source>Nucleic Acids Res.</source><year>2000</year>; <volume>28</volume>:<fpage>235</fpage>–<lpage>242</lpage>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Griep</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hobohm</surname><given-names>U.</given-names></string-name></person-group><article-title>PDBselect 1992-2009 and PDBfilter-select</article-title>. <source>Nucleic Acids Res.</source><year>2010</year>; <volume>38</volume>:<fpage>D318</fpage>–<lpage>D319</lpage>.<pub-id pub-id-type="pmid">19783827</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>On the allosteric effect of nsSNPs and the emerging importance of allosteric polymorphism</article-title>. <source>J. Mol. Biol.</source><year>2019</year>; <volume>431</volume>:<fpage>3933</fpage>–<lpage>3942</lpage>.<pub-id pub-id-type="pmid">31306666</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><collab>UniProt, C.</collab><article-title>UniProt: a worldwide hub of protein knowledge</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D506</fpage>–<lpage>D515</lpage>.<pub-id pub-id-type="pmid">30395287</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Z.</given-names></string-name></person-group><article-title>Basic units of protein structure, folding, and function</article-title>. <source>Prog. Biophys. Mol. Biol.</source><year>2017</year>; <volume>128</volume>:<fpage>85</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">27697476</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeldovich</surname><given-names>K.B.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Shakhnovich</surname><given-names>E.I.</given-names></string-name></person-group><article-title>Physical origins of protein superfamilies</article-title>. <source>J. Mol. Biol.</source><year>2006</year>; <volume>357</volume>:<fpage>1335</fpage>–<lpage>1343</lpage>.<pub-id pub-id-type="pmid">16483605</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mariani</surname><given-names>V.</given-names></string-name>, <string-name><surname>Biasini</surname><given-names>M.</given-names></string-name>, <string-name><surname>Barbato</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schwede</surname><given-names>T.</given-names></string-name></person-group><article-title>lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>2722</fpage>–<lpage>2728</lpage>.<pub-id pub-id-type="pmid">23986568</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name>, <string-name><surname>Grosberg</surname><given-names>A.Y.</given-names></string-name>, <string-name><surname>Trifonov</surname><given-names>E.N.</given-names></string-name></person-group><article-title>Closed loops of nearly standard size: common basic element of protein structure</article-title>. <source>FEBS Lett.</source><year>2000</year>; <volume>466</volume>:<fpage>283</fpage>–<lpage>286</lpage>.<pub-id pub-id-type="pmid">10682844</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goncearenco</surname><given-names>A.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Protein function from its emergence to diversity in contemporary proteins</article-title>. <source>Phys. Biol.</source><year>2015</year>; <volume>12</volume>:<fpage>045002</fpage>.<pub-id pub-id-type="pmid">26057563</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nussinov</surname><given-names>R.</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>C.J.</given-names></string-name></person-group><article-title>Latent drivers’ expand the cancer mutational landscape</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2015</year>; <volume>32</volume>:<fpage>25</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">25661093</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>W.V.</given-names></string-name>, <string-name><surname>Samsudin</surname><given-names>F.</given-names></string-name>, <string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Bond</surname><given-names>P.J.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Allosteric perspective on the mutability and druggability of the SARS-CoV-2 spike protein</article-title>. <source>Structure</source>. <year>2022</year>; <volume>30</volume>:<fpage>590</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">35063064</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>H.</given-names></string-name>, <string-name><surname>Engkvist</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Olivecrona</surname><given-names>M.</given-names></string-name>, <string-name><surname>Blaschke</surname><given-names>T.</given-names></string-name></person-group><article-title>The rise of deep learning in drug discovery</article-title>. <source>Drug Discov. Today</source>. <year>2018</year>; <volume>23</volume>:<fpage>1241</fpage>–<lpage>1250</lpage>.<pub-id pub-id-type="pmid">29366762</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>LeCun</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Bengio</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hinton</surname><given-names>G.</given-names></string-name></person-group><article-title>Deep learning</article-title>. <source>Nature</source>. <year>2015</year>; <volume>521</volume>:<fpage>436</fpage>–<lpage>444</lpage>.<pub-id pub-id-type="pmid">26017442</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Popova</surname><given-names>M.</given-names></string-name>, <string-name><surname>Isayev</surname><given-names>O.</given-names></string-name>, <string-name><surname>Tropsha</surname><given-names>A.</given-names></string-name></person-group><article-title>Deep reinforcement learning for de novo drug design</article-title>. <source>Sci. Adv.</source><year>2018</year>; <volume>4</volume>:<fpage>eaap7885</fpage>.<pub-id pub-id-type="pmid">30050984</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guarnera</surname><given-names>E.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>Z.W.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>AlloSigMA: allosteric signaling and mutation analysis server</article-title>. <source>Bioinformatics</source>. <year>2017</year>; <volume>33</volume>:<fpage>3996</fpage>–<lpage>3998</lpage>.<pub-id pub-id-type="pmid">29106449</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berezovsky</surname><given-names>I.N.</given-names></string-name></person-group><article-title>Towards descriptor of elementary functions for protein design</article-title>. <source>Curr. Opin. Struct. Biol.</source><year>2019</year>; <volume>58</volume>:<fpage>159</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">31352188</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Boyken</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Baker</surname><given-names>D.</given-names></string-name></person-group><article-title>The coming of age of de novo protein design</article-title>. <source>Nature</source>. <year>2016</year>; <volume>537</volume>:<fpage>320</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">27629638</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khersonsky</surname><given-names>O.</given-names></string-name>, <string-name><surname>Fleishman</surname><given-names>S.J.</given-names></string-name></person-group><article-title>Incorporating an allosteric regulatory site in an antibody through backbone design</article-title>. <source>Protein Sci.</source><year>2017</year>; <volume>26</volume>:<fpage>807</fpage>–<lpage>813</lpage>.<pub-id pub-id-type="pmid">28142198</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lechner</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ferruz</surname><given-names>N.</given-names></string-name>, <string-name><surname>Hocker</surname><given-names>B.</given-names></string-name></person-group><article-title>Strategies for designing non-natural enzymes and binders</article-title>. <source>Curr. Opin. Chem. Biol.</source><year>2018</year>; <volume>47</volume>:<fpage>67</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">30248579</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dang</surname><given-names>C.V.</given-names></string-name>, <string-name><surname>Reddy</surname><given-names>E.P.</given-names></string-name>, <string-name><surname>Shokat</surname><given-names>K.M.</given-names></string-name>, <string-name><surname>Soucek</surname><given-names>L.</given-names></string-name></person-group><article-title>Drugging the ‘undruggable’ cancer targets</article-title>. <source>Nat. Rev. Cancer</source>. <year>2017</year>; <volume>17</volume>:<fpage>502</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">28643779</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazo</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Sharlow</surname><given-names>E.R.</given-names></string-name></person-group><article-title>Drugging undruggable molecular cancer targets</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source><year>2016</year>; <volume>56</volume>:<fpage>23</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="pmid">26527069</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
